1015 related articles for article (PubMed ID: 17242485)
1. Clinical usefulness of probiotics in inflammatory bowel diseases.
Mach T
J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
Hedin C; Whelan K; Lindsay JO
Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
[TBL] [Abstract][Full Text] [Related]
3. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of probiotics in inflammatory bowel disease.
Cain AM; Karpa KD
Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946
[TBL] [Abstract][Full Text] [Related]
5. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
Seksik P; Dray X; Sokol H; Marteau P
Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
[TBL] [Abstract][Full Text] [Related]
6. Probiotic bacteria in the prevention and the treatment of inflammatory bowel disease.
Fedorak R; Demeria D
Gastroenterol Clin North Am; 2012 Dec; 41(4):821-42. PubMed ID: 23101689
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota and inflammatory bowel disease.
Hammer HF
Dig Dis; 2011; 29(6):550-3. PubMed ID: 22179210
[TBL] [Abstract][Full Text] [Related]
8. Do probiotics have a role in the management of inflammatory bowel disease?
Morris JD; Diamond KA; Balart LA
J La State Med Soc; 2009; 161(3):155-9. PubMed ID: 19772038
[TBL] [Abstract][Full Text] [Related]
9. Probiotics: do they help to control intestinal inflammation?
Böhm SK; Kruis W
Ann N Y Acad Sci; 2006 Aug; 1072():339-50. PubMed ID: 17057214
[TBL] [Abstract][Full Text] [Related]
10. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
Mitsuyama K; Sata M
Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
[TBL] [Abstract][Full Text] [Related]
11. Review article: antibiotics and probiotics in inflammatory bowel disease.
Kruis W
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():75-8. PubMed ID: 15352898
[TBL] [Abstract][Full Text] [Related]
12. Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
Meijer BJ; Dieleman LA
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S139-44. PubMed ID: 21992953
[TBL] [Abstract][Full Text] [Related]
13. Probiotics for inflammatory bowel disease: a critical appraisal.
Sans M
Dig Dis; 2009; 27 Suppl 1():111-4. PubMed ID: 20203506
[TBL] [Abstract][Full Text] [Related]
14. Probiotics, prebiotics and antibiotics in inflammatory bowel disease.
Cummings JH; Kong SC
Novartis Found Symp; 2004; 263():99-111; discussion 111-4, 211-8. PubMed ID: 15669637
[TBL] [Abstract][Full Text] [Related]
15. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
Prantera C; Scribano ML
Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
[TBL] [Abstract][Full Text] [Related]
16. Antibiotics and probiotics in treatment of inflammatory bowel disease.
Gionchetti P; Rizzello F; Lammers KM; Morselli C; Sollazzi L; Davies S; Tambasco R; Calabrese C; Campieri M
World J Gastroenterol; 2006 Jun; 12(21):3306-13. PubMed ID: 16733845
[TBL] [Abstract][Full Text] [Related]
17. Probiotics in luminal gastroenterology: the current state of play.
Andrews JM; Tan M
Intern Med J; 2012 Dec; 42(12):1287-91. PubMed ID: 23252997
[TBL] [Abstract][Full Text] [Related]
18. [Crohn disease, ulcerative colitis. When bacteria attack the intestinal wall....].
Duchmann R; Lochs H; Kruis W
MMW Fortschr Med; 1999 Dec; 141(51-52):48-51. PubMed ID: 10949626
[TBL] [Abstract][Full Text] [Related]
19. [Probiotics in chronic inflammatory bowel disease].
Böhm S; Kruis W
MMW Fortschr Med; 2006 Aug; 148(35-36):30-4. PubMed ID: 16995360
[TBL] [Abstract][Full Text] [Related]
20. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
Naseer M; Poola S; Ali S; Samiullah S; Tahan V
Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
